CoreWeave is Applied Digital’s anchor customer with $11B in contracted lease revenue across 400 MW of data center capacity. Applied Digital holds $2.6B in debt against $1.9B in cash and issued $2.35B ...

CoreWeave is Applied Digital’s anchor customer with $11B in contracted lease revenue across 400 MW of data center capacity. Applied Digital holds $2.6B in debt against $1.9B in cash and issued $2.35B ...

We recently published 10 Stocks Delivering Outsized Gains; 3 Are Hitting Record Highs. Applied Digital Corp. (NASDAQ:APLD) was one of the best performers on Friday. Applied Digital snapped a three-day ...

The OPPO Find N6 is rumored to introduce stylus support, possibly with AI features, alongside magnetic charging and flagship-level specs. If true, it could help OPPO further differentiate its ...

Applied Digital Corporation maintains a Buy rating as fundamentals strengthen, and the growth outlook brightens, despite recent stock volatility. APLD delivered 250% YoY revenue growth in FY2026 Q2, ...

Electric scooters have evolved way beyond simple last-mile transportation. The NANROBOT N6 72V represents what happens when manufacturers focus on genuine performance instead of just checking boxes.

Oppo appears to be building out another new foldable for 2026, with the Find N6 set to deliver a camera upgrade while also addressing some other key specs. The Oppo Find N5 that launched earlier this ...

The most insane part of the leak is the camera. Most foldables are too thin to fit a big lens, so they settle for "good enough." OPPO is reportedly stuffing a 200MP sensor into the Find N6. Under the ...

The data center developer enjoys an unusually high level of demand visibility. Applied Digital is transitioning from construction to recurring revenue generation. Management expects to reach $1 ...

A new leak suggests OPPO may launch its next flagships earlier than usual, with the Find N6 foldable arriving before Chinese New Year and the Find X9 Ultra launching in China around March. If accurate ...

Facing skepticism from analysts about whether it has the resources to take its rare disease drug to market, Applied Therapeutics is laying off almost half of the biotech's workforce to conserve its ...